Circular Genomics, Inc. is a global leader in the development of circular RNA (circRNA) biomarkers, focusing on precision neurology and psychiatry. The company specializes in creating innovative blood-based diagnostic tools for neurological disorders, including Alzheimer's disease, aiming to enhance diagnostic accuracy and predict disease progression.
Leadership & Board
Current Number of Employees18
Current LinkedIn Followers7,714
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$15M
Total Amount Raised$15M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$15M
Latest Funding Amount$15M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Circular Genomics had 18 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Circular Genomics had 7,714 followers as of September 14, 2026. The number of followers increased by 63 (0.82%) week-over-week.
7,714Latest Followers Count
63(0.82%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.